About   Help   FAQ
Phenotype Image Detail
Image
Caption Hepatic steatosis in C3tm1Crr/C3tm1Crr (C3-/-) and C5ar2tm1Gdy/C5ar2tm1Gdy (C5L2-/-) mice following partial hepatectomy (PHx). (A) Representative H&E-stained sections showing C3 and C5L2 deficiency is associated with a marked increase in necrosis with hepatic micro- and macrovesicular steatosis, whereas wild-type (WT) mice and C3-/- mice treated with 15 ug acylation-stimulating protein (ASP) exhibit much less apparent steatosis. (B) Representative oil red O-stained sections. Both homozygous mutant mice have increased micro- and macrovesicular steatosis compared with WT mice and C3-/- mice treated with 15 ug ASP. Original magnification in A and B, 400. (C) Quantification of hepatic triglyceride accumulation. ##P < 0.01 versus WT groups; **P < 0.01 versus C3-/- groups. Results expressed as mean SD; n = 4-6.
Copyright This image is from He S, J Clin Invest 2009 Aug;119(8):2304-16 and is displayed with the permission of the American Society for Clinical Investigation who owns the Copyright. J:152533
Associated
Alleles
Symbol Name
C3tm1Crr complement component 3; targeted mutation 1, Michael C Carroll
C5ar2tm1Gdy complement component 5a receptor 2; targeted mutation 1, George D Yancopoulos
Associated
Genotypes
Allelic Composition Genetic Background
C3tm1Crr/C3tm1Crr involves: 129S4/SvJae * C57BL/6
C5ar2tm1Gdy/C5ar2tm1Gdy involves: 129 * C57BL/6

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory